United States: Proposed Rulemaking Under ECRA Signals Tightening Of Export Control Restrictions

On November 19, 2018, the U.S. government took a new step in implementing tighter controls over certain technologies in what appears to be efforts to keep what it considers critical technology out of the hands of rivals. Recently, the U.S. Department of Commerce, Bureau of Industry and Security ("BIS") published an advance notice of proposed rulemaking ("ANPRM") under the Export Control Reform Act of 2018 ("ECRA") initiating a 30-day public comment process for defining and identifying emerging technologies that are essential to U.S. national security. The ANPRM, as noted above, represents a preliminary step in the process of establishing new export control restrictions under the ECRA that will also affect the scope of the Committee on Foreign Investment of the United States' ("CFIUS") jurisdiction.

The ECRA, which was signed on August 13, 2018, creates a permanent statutory authority for the Export Administration Regulations ("EAR"), which governs export controls concerning commercial and dual-use items (i.e., items that have civil and less-sensitive military applications) and the anti-boycott regulations, both of which are administered by BIS. The EAR was originally implemented under the Export Administration Act ("EAA"), which lapsed in 1994 and has since been maintained in effect through executive orders under the International Emergency Economic Powers Act.

Aside from codifying existing practice, as further discussed below, the ECRA significantly changes U.S. export controls by placing a new emphasis and potential controls on, among other things, "emerging and foundational technologies" and by amending the export licensing process to require weighing whether exports will have a "significantly negative impact on the United States defense industrial base."


Section 1758 of the ECRA calls for the U.S. Departments of Commerce, Defense, Energy, State, and other agencies to coordinate a regular, ongoing process to identify "emerging and foundational technologies" that are essential to the national security of the United States. The law requires BIS to establish controls under the EAR to protect these technologies. While BIS has discretion in setting the level of export controls, at a minimum, these controls must include a license requirement for export to countries subject to an embargo, including an arms embargo, imposed by the United States (e.g., China and Venezuela). Also, in the context of reviewing license applications submitted by or on behalf of a joint venture or joint development agreement, BIS may require the applicant to identify any foreign person with a significant ownership interest in a foreign person participating in the agreement.

Review Process

The review process will be informed by: (i) publicly available information; (ii) classified information; (iii) information relating to reviews and investigations of transactions by CFIUS; and (iv) certain advisory committees (e.g., the Emerging Technology and Research Advisory Committee). Consequently, the ECRA will likely lead to an increase in information-sharing among national security agencies. The ECRA requires that the proposed technologies (and the export controls on such technologies) be introduced through a notice and comment period, which will consider the following: (i) the development of "emerging and foundational technologies" in foreign countries; (ii) the effect export controls may have on the development of such technologies in the United States; and (iii) the effectiveness of export controls on limiting the proliferation of "emerging and foundational technologies" to foreign countries.

"Emerging and Foundational Technologies"

The terms "emerging technologies," "foundational technologies," and "essential to national security" are not defined in the ECRA. However, as mentioned above, BIS published an ANPRM initiating a 30-day public comment process for defining and identifying emerging technologies that are essential to U.S. national security. The ANPRM includes 14 representative technology categories from which BIS seeks to determine whether there are specific emerging technologies: (1) biotechnology; (2) artificial intelligence and machine learning technology; (3) position, navigation, and timing technology: (4) microprocessor technology; (5) advanced computing technology; (6) data analytics technology; (7) quantum information and sensing technology; (8) logistics technology; (9) additive manufacturing (e.g., 3D printing); (10) robotics; (11) brain–computer interfaces; (12) hypersonics; (13) advanced materials; and (14) advanced surveillance technologies. Notably, these categories cover only "emerging" technologies, and the ANPRM indicates that BIS will issue a separate ANPRM regarding identification of foundational technologies.

After the comment period, BIS will issue another advance notice identifying specific "emerging and foundational" technologies and then issue controls on the export, re-export, or transfer of those technologies. As mentioned above, at a minimum, companies with "emerging and foundational" technologies will need a license to export those technologies to countries subject to a U.S. embargo, including an arms embargo (e.g., China and Venezuela). In addition, if a foreign person seeks to invest in a U.S. business that "produces, designs, tests, manufactures, fabricates, or develops" an "emerging or foundational" technology, the parties to that transaction may be required to file a mandatory declaration with CFIUS.

Companies operating in the representative technology categories above should consider submitting comments regarding whether their technologies should be deemed or not deemed "emerging and foundational." In addition, those companies will want to consider, among other items, how unilateral export controls on such technologies could have significant, burdensome implications for deemed exports and technology transfer licensing requirements. For example, companies exporting, re-exporting, or transferring such "emerging" technologies to non-U.S. customers will likely require export licenses, which could result in delays or reductions in sales. Further, the changes could drastically affect supply chain operations and research and development being performed on such technologies by foreign persons overseas or in the United States.

Reports to CFIUS and Congress

Under the ECRA, every 180 days, the agencies described above will be required to submit a report to CFIUS and Congress on the results of the review process.


Section 1756(d)(1) of the ECRA modifies the export license review process to include a requirement that BIS assess the impact of a proposed export of an item on the U.S. defense industrial base and deny an application if the export would have a "significant negative impact" on the U.S. defense industrial base. Accordingly, license applications will be required to provide relevant information to this effect, including a statement on whether the purpose or effect of the export is to allow for the significant production of items relevant to the defense industrial base outside of the United States.

Significant Negative Impact

In assessing whether a given export may have a significant negative impact on the U.S. defense industrial base, among other things, BIS will consider whether the export will constitute a reduction in:

  • The availability of a U.S. item that is likely to be acquired by the U.S. Department of Defense ("DoD") or other departments or agencies for the advancement of U.S. national security;
  • The production of a U.S. item that resulted from research and development carried out or funded by the DoD or other departments or agencies for the advancement of U.S. national security; and
  • The employment of U.S. persons with the knowledge and skills necessary for the continued production in the United States of an item that is likely to be acquired by the DoD or other departments or agencies for the advancement of U.S. national security.


The EAR currently controls items subject to U.S. jurisdiction and U.S. persons, wherever located, with regard to certain activities, including activities related to nuclear explosive devices, foreign military nuclear projects, missiles, and chemical or biological weapons. Section 1753 of the EAR expands controls over activities of U.S. persons, wherever located, to include activities related to "foreign military intelligence services." At this time, it is unclear how BIS will implement such controls.


Section 1759(a) of the ECRA requires BIS, in coordination with other agencies, to conduct a review of license requirements for exports, reexports, or in-country transfers of items to countries subject to a comprehensive U.S. arms embargo. This includes a review of items controlled for anti-terrorism reasons to determine if licensing restrictions should be expanded to countries subject to an arms embargo. Although countries are not specifically referenced, this provision would impact items destined for countries subject to an arms embargo, such as China and Venezuela. The ECRA calls for BIS to implement the results of such review by May 9, 2019.


 Section 1760 of the ECRA increases civil penalties for violations of the EAR from $295,141 to up to $300,000 per violation or an amount that is twice the value of the transaction, whichever is greater. Civil penalties still include the ability to impose denial of export privileges. Criminal penalties for willful violations remain at $1 million per violation and, in the case of an individual, up to 20 years in prison (or both). With respect to enforcement, among other things, the ECRA allows BIS to conduct investigations within the United States and outside the United States consistent with applicable law.

The ECRA requires BIS and other relevant agencies to publish and update "best practices" guidelines to assist persons in developing and implementing effective export control programs, which, as a reminder, the ECRA notes will be given weight as a mitigating factor in a civil penalty action. BIS will also establish a system to provide U.S. persons, particularly small- and medium-sized U.S. businesses, assistance in complying with U.S. export controls, including arrangements for BIS to provide counseling to businesses on filing applications and identifying controlled items and seminars and conferences to educate businesses on export controls, licensing procedures, and related obligations.


Companies dealing in the representative technology categories described above, which will be used to assist BIS with defining and identifying "emerging" technologies, should consider participating in the comment process to lessen the impact that heightened export controls could have on its technologies. In addition, companies should begin evaluating the impact that export control restrictions could have on sales outside the United States, supply chain arrangements, collaborative agreements with foreign countries involving such technologies, and research and development being performed on such technologies by foreign persons.

Companies in the aerospace, defense, or military intelligence industries may be impacted by the risk of denials of export licenses if any exports may result in a "significant negative impact" on the U.S. defense industrial base and/or increased licensing obligations due to the provision of certain services by U.S. persons.

Companies should evaluate their current export control compliance programs and internal controls to take into account the ECRA's changes to the export license review process and expanded controls on certain activities of U.S. persons, and evaluate whether any of its technologies could be considered "emerging and foundational technologies."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions